Horizon Therapeutics Public Ltd Co

Swiss National Bank

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/8/2023

Shares

699,656

Value ($000)

80,943

Weight

0.1%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/8/2023	80,943	0.1%	699,656	9/30/2023
2023 Q2	8/9/2023	80,620	0.1%	783,856	6/30/2023
2023 Q1	5/10/2023	93,244	0.1%	854,356	3/31/2023
2022 Q4	2/8/2023	101,231	0.1%	889,556	12/31/2022
2022 Q3	11/9/2022	58,577	0.0%	946,468	9/30/2022
2022 Q2	8/9/2022	74,437	0.1%	933,268	6/30/2022
2022 Q1	5/9/2022	98,189	0.1%	933,268	3/31/2022
2021 Q4	2/8/2022	87,896	0.1%	815,668	12/31/2021
2021 Q3	11/8/2021	92,514	0.1%	844,568	9/30/2021
2021 Q2	8/6/2021	81,277	0.1%	867,968	6/30/2021
2021 Q1	5/7/2021	78,120	0.1%	848,756	3/31/2021
2020 Q4	2/5/2021	60,865	0.0%	832,056	12/31/2020
2020 Q3	11/9/2020	32,273	0.0%	415,456	9/30/2020
2020 Q2	8/5/2020	23,591	0.0%	424,456	6/30/2020
2020 Q1	5/8/2020	10,760	0.0%	363,256	3/31/2020
2019 Q4	2/6/2020	12,922	0.0%	356,956	12/31/2019